07.05.2014 • Topics

Cooperation Creates Broad Portfolio at Best Market Price

Dr. Bernd Soyke, CEO, Penta
Dr. Bernd Soyke, CEO, Penta

What kind of growth do you aspire to in the next few years?

We expect organic growth through expansion of our customer and product portfolio as well as offering new services to our customers.

In which sectors, markets or regions do you see significant growth opportunities?

Generally, we see opportunities in all sectors where we are active. As a cooperation network with focus on the European chemical distribution segment, we have growth opportunities in many different regions, markets and sectors.

How do you intend to implement these plans and seize these opportunities?

Penta takes its chances out of the cooperation. Our shareholding companies as well as our cooperation partners form a strong alliance in order to offer our customers a broad product and service portfolio in virtually every place in Europe at the best market price possible. This has been our success factor for almost 50 years.

 

Company

Penta Chemikalien GmbH & Co.KG


Mainaschaff
Germany

Company contact







From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read